Is Tofacitinib a domestic drug or an imported one?

Tofacitinib/Shangjie（Tofacitinib) is an imported original drug, developed by international pharmaceutical companies and registered and marketed in many countries around the world. As an original drug, its research and development has undergone systematic clinical research verification, and there are strict standards for drug quality, stability and pharmacological effects. Imported drugs have international certification in terms of drug production technology, preparation purity and drug consistency, ensuring the efficacy and safety of the drugs in clinical use.

In contrast, some domestic manufacturers have begun to develop generic drugs of tofacitinib, but Shangjie, as the original drug, still maintains globally unified prescription standards and instructions for the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis (UC), ankylosing spondylitis, etc.. Imported drugs are usually more complete in terms of packaging, drug information transparency and regulatory systems, especially in long-term maintenance treatment and cross-center use, making it easier to achieve consistency in dosage and efficacy.

At the market and price level, as an imported drug, Sanjetofatinib is relatively expensive, but it is also included in some medical insurance reimbursement lists, so that patients can obtain it through formal channels in hospital pharmacies. Its import status also means that patients can obtain complete drug information, official medication guidance, and international clinical data references when taking medications, which is an important guarantee of safety and predictability for patients with rheumatoid arthritis who require long-term management.

Overall, Shangjie tofacitinib, as an imported original drug, not only represents the original research standard for tofacitinib in the treatment of rheumatoid arthritis and other autoimmune diseases, but also provides patients with reliable drug quality assurance. For clinicians, choosing imported drugs means that treatment plans can be formulated more accurately with reference to international clinical data, and at the same time, there is more basis for monitoring side effects and evaluating efficacy.

Reference materials:https://www.xeljanz.com/